Originally published by our sister publication Specialty Pharmacy Continuum
By Myles Starr
Patients with chronic hepatitis C virus (HCV) suffer from severe morbidity and mortality, including potentially fatal cirrhosis or liver cancer (SN Compr Clin Med 2020;2[12]:2808-15). Although more than 95% of HCV can be cured with direct-acting antivirals (DAAs), confirming effective treatment requires a test for sustained virologic response (SVR) at least 12 weeks after completion of therapy, and many